Hagerty David T 4
4 · Conatus Pharmaceuticals Inc. · Filed Feb 5, 2018
Insider Transaction Report
Form 4
Hagerty David T
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2018-02-04+70,000→ 70,000 totalExercise: $5.17Exp: 2028-02-03→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 4, 2018. 25% of the total number of shares of common stock subject to the option will vest on February 2, 2019, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.